Literature DB >> 15892713

WNT1 and WNT3a promote expansion of melanocytes through distinct modes of action.

Karen Joyce Dunn1, Matthew Brady, Christina Ochsenbauer-Jambor, Sara Snyder, Arturo Incao, William J Pavan.   

Abstract

Summary WNT1 and WNT3a have been described as having redundant roles in promoting the development of neural crest-derived melanocytes (NC-Ms). We used cell lineage restricted retroviral infections to examine the effects of WNT signaling on defined cell types in neural crest cultures. RCAS retroviral infections were targeted to melanoblasts (NC-M precursor cells) derived from transgenic mice that express the virus receptor, TVA, under the control of a melanoblast promoter (DCT). As expected, over 90% of DCT-TVA+ cells expressed early melanoblast markers MITF and KIT. However, by following the fate of infected cells in standard culture conditions, we find that only 5% of descendents were NC-Ms. The majority of the descendents were not NC-Ms, but expressed smooth muscle cell markers, demonstrating that mammalian melanoblasts are not committed to the NC-M lineage. RCAS infection of DCT-TVA+ cells demonstrated that overexpression of canonical WNT signaling genes (betaCAT, WNT3a or WNT1) can increase NC-M numbers in an endothelin dependent manner. However, WNT1 and WNT3a have different modes of action with respect to melanoblast fate. Intrinsic over-expression of betaCAT or WNT3a can increase NC-M numbers by biasing the fate of DCT-TVA+ cells to NC-Ms. In contrast, the DCT-TVA+ melanoblasts cannot respond to WNT1 signaling and do not alter their fate towards NC-M. Instead, WNT1 only increases NC-M numbers through paracrine signaling on melanoblast precursors to increase the numbers of neural crest cells that become NC-Ms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15892713     DOI: 10.1111/j.1600-0749.2005.00226.x

Source DB:  PubMed          Journal:  Pigment Cell Res        ISSN: 0893-5785


  25 in total

1.  Isolation of a mesenchymal cell population from murine dermis that contains progenitors of multiple cell lineages.

Authors:  Lauren Crigler; Amita Kazhanie; Tae-Jin Yoon; Julia Zakhari; Joanna Anders; Barbara Taylor; Victoria M Virador
Journal:  FASEB J       Date:  2007-03-23       Impact factor: 5.191

2.  Targeted delivery of NRASQ61R and Cre-recombinase to post-natal melanocytes induces melanoma in Ink4a/Arflox/lox mice.

Authors:  Matthew W VanBrocklin; James P Robinson; Kristin J Lastwika; Joseph D Khoury; Sheri L Holmen
Journal:  Pigment Cell Melanoma Res       Date:  2010-04-23       Impact factor: 4.693

3.  CtBP2 downregulation during neural crest specification induces expression of Mitf and REST, resulting in melanocyte differentiation and sympathoadrenal lineage suppression.

Authors:  Hongzi Liang; Donna M Fekete; Ourania M Andrisani
Journal:  Mol Cell Biol       Date:  2011-01-03       Impact factor: 4.272

Review 4.  Specification of neural crest into sensory neuron and melanocyte lineages.

Authors:  William J Pavan; David W Raible
Journal:  Dev Biol       Date:  2012-03-10       Impact factor: 3.582

5.  Activation of the canonical Wnt/β-catenin signalling pathway is rare in canine malignant melanoma tissue and cell lines.

Authors:  E Chon; V Thompson; S Schmid; T J Stein
Journal:  J Comp Pathol       Date:  2012-08-14       Impact factor: 1.311

Review 6.  G-protein-coupled receptors and melanoma.

Authors:  Hwa Jin Lee; Brian Wall; Suzie Chen
Journal:  Pigment Cell Melanoma Res       Date:  2008-05-27       Impact factor: 4.693

Review 7.  Hear the Wnt Ror: how melanoma cells adjust to changes in Wnt.

Authors:  Michael P O'Connell; Ashani T Weeraratna
Journal:  Pigment Cell Melanoma Res       Date:  2009-08-25       Impact factor: 4.693

Review 8.  Mechanisms for reaching the differentiated state: Insights from neural crest-derived melanocytes.

Authors:  Cynthia D Cooper; David W Raible
Journal:  Semin Cell Dev Biol       Date:  2008-09-30       Impact factor: 7.727

Review 9.  Wnt-signaling and senescence: A tug of war in early neoplasia?

Authors:  Peter D Adams; Greg H Enders
Journal:  Cancer Biol Ther       Date:  2008-11-07       Impact factor: 4.742

10.  A sensitized mutagenesis screen identifies Gli3 as a modifier of Sox10 neurocristopathy.

Authors:  Ivana Matera; Dawn E Watkins-Chow; Stacie K Loftus; Ling Hou; Arturo Incao; Debra L Silver; Cecelia Rivas; Eugene C Elliott; Laura L Baxter; William J Pavan
Journal:  Hum Mol Genet       Date:  2008-04-07       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.